We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-43.14%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$100M
AUM Growth
-$36.6M
Cap. Flow
-$10.6M
Cap. Flow %
-10.62%
Top 10 Hldgs %
93.38%
Holding
105
New
21
Increased
12
Reduced
17
Closed
48

Top Buys

Rank Stock Value
1
AIRE icon
reAlpha
AIRE
+$3.43M
2
FMTO
Femto Technologies Inc. Common Stock
FMTO
+$2.56M
3
GGE
Green Giant Inc. Common Stock
GGE
+$2.37M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$1.64M
5
PHUN icon
Phunware
PHUN
+$1.41M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$12.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.67M
3
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$2.17M
4
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$817K
5
AIOS
AIOS Tech
AIOS
+$528K

Sector Composition

Rank Sector Weight
1 Technology 4.2%
2 Healthcare 3.82%
3 Energy 0.81%
4 Real Estate 0.76%
5 Materials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIO
51
PUT
DELISTED
Tingo Group, Inc. Common Stock
TIO
$11K 0.01%
160
+12
+8% +$10
EOSE icon
52
PUT
Eos Energy Enterprises
EOSE
$1.22B
$10.9K 0.01%
+100
New +$146
ARQQ icon
53
Arqit Quantum
ARQQ
$305M
$9.39K 0.01%
793
+247
+45% +$3.12K
OPTT icon
54
Ocean Power Technologies
OPTT
$40.6M
$8.4K 0.01%
26,597
– –
NEXRW
55
Nexera Technologies Ltd Warrant
NEXRW
$1.55K ﹤0.01%
77,282
– –
BRSHW
56
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$1.21K ﹤0.01%
177,542
-373,916
-68% -$3.59K
ALLR
57
Allarity Therapeutics
ALLR
$18.8M
– –
-599
Closed -$268K
BNBX
58
DELISTED
BNB PLUS CORP
BNBX
– –
-3
Closed -$47.1K
BCLI
59
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-203
Closed -$61K
BCLI
60
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-9,099
Closed -$27.3K
BCLI
61
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-7
Closed -$2.12K
BCTXW
62
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
– –
-712
Closed -$445K
BFRGW icon
63
Bullfrog AI Holdings Warrants
BFRGW
$155K
– –
-145,090
Closed -$82.2K
BLRX
64
BioLineRX
BLRX
$12.2M
– –
-5,250
Closed -$382K
BLRX
65
PUT
BioLineRX
BLRX
$12.2M
– –
-69
Closed -$504K
CAN
66
CALL
Canaan Creative
CAN
$178M
– –
-141
Closed -$25.7K
CISS
67
C3is
CISS
$248K
– –
0
– -$4.68K
CKPT
68
DELISTED
Checkpoint Therapeutics
CKPT
– –
-205,247
Closed -$447K
CTRM icon
69
Castor Maritime
CTRM
$18.3M
– –
-8,240
Closed -$36K
CTRM icon
70
PUT
Castor Maritime
CTRM
$18.3M
– –
-82
Closed -$36K
DOGZ icon
71
Dogness International Corp
DOGZ
$14M
– –
-55,181
Closed -$519K
ENSC icon
72
Ensysce Biosciences
ENSC
$3.86M
– –
-6,465
Closed -$134K
EZGO
73
EZGO Technologies
EZGO
$2.17M
– –
-19
Closed -$406K
IWM icon
74
iShares Russell 2000 ETF
IWM
$80.4B
– –
-73,000
Closed -$12.9M
LEXXW
75
DELISTED
Lexaria Bioscience Warrant
LEXXW
– –
-209,979
Closed -$42K
1 2
3
4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2023 Portfolio in Review

As of Q4 2023, Sabby Management held 105 positions worth $100M, down 27% from $137M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Sabby Management withdrew a net $10.6M in Q4 2023, closing 48 positions and reducing 17 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, up from 0.43% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Sabby Management opened a new position in reAlpha worth $370K.

  • Sabby Management's largest Q4 2023 buy was reAlpha: 7,430 shares worth $370K.
  • Sabby Management added most to Tonix Pharmaceuticals in Q4 2023, an estimated $929K increase.
  • Sabby Management's biggest Q4 2023 reduction was GlucoTrack, cutting an estimated $349K.
  • Sabby Management fully exited iShares Russell 2000 ETF in Q4 2023, selling an estimated $12.9M.
  • Sabby Management's ten largest holdings make up 93% of its $100M portfolio in Q4 2023.
  • Sabby Management opened 21 new positions and closed 48 in Q4 2023.
  • Sabby Management's portfolio value fell 27% quarter-over-quarter to $100M.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.